Peripheral complement interactions with amyloid β peptide

Erythrocyte clearance mechanisms

William D. Brubaker, Andrés Crane, Jenny U. Johansson, Kevin Yen, Kristina Garfinkel, Diego Mastroeni, Priya Asok, Bonnie Bradt, Marwan Sabbagh, Tanya L. Wallace, Courtney Glavis-Bloom, Andrea J. Tenner, Joseph Rogers

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction: Although amyloid β peptide (Aβ) is cleared from the brain to cerebrospinal fluid and the peripheral circulation, mechanisms for its removal from blood remain unresolved. Primates have uniquely evolved a highly effective peripheral clearance mechanism for pathogens, immune adherence, in which erythrocyte complement receptor 1 (CR1) plays a major role. Methods: Multidisciplinary methods were used to demonstrate immune adherence capture of Aβ by erythrocytes and its deficiency in Alzheimer's disease (AD). Results: Aβ was shown to be subject to immune adherence at every step in the pathway. Aβ dose-dependently activated serum complement. Complement-opsonized Aβ was captured by erythrocytes via CR1. Erythrocytes, Aβ, and hepatic Kupffer cells were colocalized in the human liver. Significant deficits in erythrocyte Aβ levels were found in AD and mild cognitive impairment patients. Discussion: CR1 polymorphisms elevate AD risk, and >80% of human CR1 is vested in erythrocytes to subserve immune adherence. The present results suggest that this pathway is pathophysiologically relevant in AD.

Original languageEnglish (US)
Pages (from-to)1397-1409
Number of pages13
JournalAlzheimer's and Dementia
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Amyloid
Complement C1
Complement Receptors
Erythrocytes
Peptides
Alzheimer Disease
Kupffer Cells
Primates
Cerebrospinal Fluid
Hepatocytes
Liver
Brain
Serum

Keywords

  • Alzheimer's disease
  • Amyloid β peptide
  • Blood
  • Complement
  • Complement receptor 1
  • Erythrocyte
  • Human
  • Immune adherence

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Brubaker, W. D., Crane, A., Johansson, J. U., Yen, K., Garfinkel, K., Mastroeni, D., ... Rogers, J. (2017). Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms. Alzheimer's and Dementia, 13(12), 1397-1409. https://doi.org/10.1016/j.jalz.2017.03.010

Peripheral complement interactions with amyloid β peptide : Erythrocyte clearance mechanisms. / Brubaker, William D.; Crane, Andrés; Johansson, Jenny U.; Yen, Kevin; Garfinkel, Kristina; Mastroeni, Diego; Asok, Priya; Bradt, Bonnie; Sabbagh, Marwan; Wallace, Tanya L.; Glavis-Bloom, Courtney; Tenner, Andrea J.; Rogers, Joseph.

In: Alzheimer's and Dementia, Vol. 13, No. 12, 01.12.2017, p. 1397-1409.

Research output: Contribution to journalArticle

Brubaker, WD, Crane, A, Johansson, JU, Yen, K, Garfinkel, K, Mastroeni, D, Asok, P, Bradt, B, Sabbagh, M, Wallace, TL, Glavis-Bloom, C, Tenner, AJ & Rogers, J 2017, 'Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms', Alzheimer's and Dementia, vol. 13, no. 12, pp. 1397-1409. https://doi.org/10.1016/j.jalz.2017.03.010
Brubaker, William D. ; Crane, Andrés ; Johansson, Jenny U. ; Yen, Kevin ; Garfinkel, Kristina ; Mastroeni, Diego ; Asok, Priya ; Bradt, Bonnie ; Sabbagh, Marwan ; Wallace, Tanya L. ; Glavis-Bloom, Courtney ; Tenner, Andrea J. ; Rogers, Joseph. / Peripheral complement interactions with amyloid β peptide : Erythrocyte clearance mechanisms. In: Alzheimer's and Dementia. 2017 ; Vol. 13, No. 12. pp. 1397-1409.
@article{ddf8e3499d66448f87cebe71a6d1c9f0,
title = "Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms",
abstract = "Introduction: Although amyloid β peptide (Aβ) is cleared from the brain to cerebrospinal fluid and the peripheral circulation, mechanisms for its removal from blood remain unresolved. Primates have uniquely evolved a highly effective peripheral clearance mechanism for pathogens, immune adherence, in which erythrocyte complement receptor 1 (CR1) plays a major role. Methods: Multidisciplinary methods were used to demonstrate immune adherence capture of Aβ by erythrocytes and its deficiency in Alzheimer's disease (AD). Results: Aβ was shown to be subject to immune adherence at every step in the pathway. Aβ dose-dependently activated serum complement. Complement-opsonized Aβ was captured by erythrocytes via CR1. Erythrocytes, Aβ, and hepatic Kupffer cells were colocalized in the human liver. Significant deficits in erythrocyte Aβ levels were found in AD and mild cognitive impairment patients. Discussion: CR1 polymorphisms elevate AD risk, and >80{\%} of human CR1 is vested in erythrocytes to subserve immune adherence. The present results suggest that this pathway is pathophysiologically relevant in AD.",
keywords = "Alzheimer's disease, Amyloid β peptide, Blood, Complement, Complement receptor 1, Erythrocyte, Human, Immune adherence",
author = "Brubaker, {William D.} and Andr{\'e}s Crane and Johansson, {Jenny U.} and Kevin Yen and Kristina Garfinkel and Diego Mastroeni and Priya Asok and Bonnie Bradt and Marwan Sabbagh and Wallace, {Tanya L.} and Courtney Glavis-Bloom and Tenner, {Andrea J.} and Joseph Rogers",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.jalz.2017.03.010",
language = "English (US)",
volume = "13",
pages = "1397--1409",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Peripheral complement interactions with amyloid β peptide

T2 - Erythrocyte clearance mechanisms

AU - Brubaker, William D.

AU - Crane, Andrés

AU - Johansson, Jenny U.

AU - Yen, Kevin

AU - Garfinkel, Kristina

AU - Mastroeni, Diego

AU - Asok, Priya

AU - Bradt, Bonnie

AU - Sabbagh, Marwan

AU - Wallace, Tanya L.

AU - Glavis-Bloom, Courtney

AU - Tenner, Andrea J.

AU - Rogers, Joseph

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Introduction: Although amyloid β peptide (Aβ) is cleared from the brain to cerebrospinal fluid and the peripheral circulation, mechanisms for its removal from blood remain unresolved. Primates have uniquely evolved a highly effective peripheral clearance mechanism for pathogens, immune adherence, in which erythrocyte complement receptor 1 (CR1) plays a major role. Methods: Multidisciplinary methods were used to demonstrate immune adherence capture of Aβ by erythrocytes and its deficiency in Alzheimer's disease (AD). Results: Aβ was shown to be subject to immune adherence at every step in the pathway. Aβ dose-dependently activated serum complement. Complement-opsonized Aβ was captured by erythrocytes via CR1. Erythrocytes, Aβ, and hepatic Kupffer cells were colocalized in the human liver. Significant deficits in erythrocyte Aβ levels were found in AD and mild cognitive impairment patients. Discussion: CR1 polymorphisms elevate AD risk, and >80% of human CR1 is vested in erythrocytes to subserve immune adherence. The present results suggest that this pathway is pathophysiologically relevant in AD.

AB - Introduction: Although amyloid β peptide (Aβ) is cleared from the brain to cerebrospinal fluid and the peripheral circulation, mechanisms for its removal from blood remain unresolved. Primates have uniquely evolved a highly effective peripheral clearance mechanism for pathogens, immune adherence, in which erythrocyte complement receptor 1 (CR1) plays a major role. Methods: Multidisciplinary methods were used to demonstrate immune adherence capture of Aβ by erythrocytes and its deficiency in Alzheimer's disease (AD). Results: Aβ was shown to be subject to immune adherence at every step in the pathway. Aβ dose-dependently activated serum complement. Complement-opsonized Aβ was captured by erythrocytes via CR1. Erythrocytes, Aβ, and hepatic Kupffer cells were colocalized in the human liver. Significant deficits in erythrocyte Aβ levels were found in AD and mild cognitive impairment patients. Discussion: CR1 polymorphisms elevate AD risk, and >80% of human CR1 is vested in erythrocytes to subserve immune adherence. The present results suggest that this pathway is pathophysiologically relevant in AD.

KW - Alzheimer's disease

KW - Amyloid β peptide

KW - Blood

KW - Complement

KW - Complement receptor 1

KW - Erythrocyte

KW - Human

KW - Immune adherence

UR - http://www.scopus.com/inward/record.url?scp=85019553464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019553464&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2017.03.010

DO - 10.1016/j.jalz.2017.03.010

M3 - Article

VL - 13

SP - 1397

EP - 1409

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 12

ER -